Induction of Cytochrome P450s by Rutaecarpine and Metabolism of Rutaecarpine by Cytochrome P450s

Abstract

Rutaecarpine is an alkaloid originally isolated from the unripe fruit of Evodia rutaecarpa. Recently, rutaecarpine has been characterized to have an anti-inflammatory activity through cyclooxygenase-2 inhibition. In the present studies, the effects of rutaecarpine on liver cytochrome P450 s (P450s) and P450 s involved in the metabolism of rutaecarpine were studied in vivo and in vitro, respectively, because the data are crucial in the early development of rutaecarpine as a new drug candidate. Oral administration to male ICR mice of rutaecarpine for 3 consecutive days induced liver P450 1A-, 2B- and 2E1-selective monooxygenase activities. The induction of P450 1A and 2B by rutaecarpine was confirmed by Western immunoblotting. When rutaecarpine was incubated with rat liver microsomes in the presence of an NADPH-generating system, five metabolites were detected by UV and mass spectral analyses. The 3-methylcholanthrene- and phenobarbital-induced microsomes greatly increased the formation of metabolites. Our present results suggest that rutaecarpine might induce P450 1A and 2B in mice, and that P450 1A and 2B might predominantly metabolize rutaecarpine in rat liver microsomes.

Key words

Rutaecarpine - Evodia rutaecarpa - Rutaceae - induction - cytochrome P450s - metabolism - liver microsomes - metabolites

References

• 1 Chiou W F, Liao J P, Chen C F. Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa .  J Nat Prod. 1996;  59 374-8
• 2 Moon T C, Murakami M, Kudo I, Son K H, Kang S S, Chang H W. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa .  Inflamm Res. 1999;  48 621-5
• 3 Woo H G, Lee C H, Noh M S, Lee J J, Jung Y S, Baik E J, Moon C H, Lee S H. Rutaecarpine, a quinazolinocarboline alkaloid, inhibits prostaglandin production in RAW264.7 macrophages.  Planta Med. 2001;  67 505-9
• 4 Lee S H, Kim S I, Park J G, Lee E S, Jahng Y. A simple synthesis of rutaecarpine.  Heterocycles. 2001;  55 1555-9
• 5 Guengerich F P. Role of cytochrome P450 enzymes in drug-drug interactions.  Adv Phamacol. 1997;  43 7-35
• 6 Ueng Y F, Wang J J, Lin L C, Park S S, Chen C F. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa .  Life Sci. 2001;  70 207-17
• 7 Ueng Y F, Ko H C, Chen C F, Wang J J, Chen K T. Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice.  Life Sci. 2002;  71 1267-77
• 8 Ueng Y F, Jan W C, Lin L C, Chen T L, Guengerich F P, Chen C F. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.  Drug Metab Dispos. 2002;  30 349-53
• 9 Lowry O H, Rosenbrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent.  J Biol Chem. 1951;  193 265-75
• 10 Kim H J, Chun Y J, Park J D, Kim S I, Roh J K, Jeong T C. Protection of rat liver microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition.  Planta Medica. 1997;  63 415-8
• 11 Jeong H G, Yun C H. Induction of rat hepatic cytochrome P450 enzymes by myristicin.  Biochem Biophys Res Commun. 1995;  217 966-71
• 12 Jeong T C, Gu H K, Chun Y J, Yun C H, Han S S, Roh J K. Effects of β-ionone on the expression of cytochrome P450 s and NADPH-cytochrome P450 reductase in Sprague Dawley rats.  Chem-Biol Interact. 1998;  114 97-107
• 13 Ko H C, Tsai T H, Chou C J, Hsu S Y, Li S Y, Chen C F. High-performance liquid chromatographic determination of rutaecarpine in rat plasma: application to a pharmacokinetic study.  J Chromatogr B. 1994;  655 27-31
• 14 Lee S K, Lee J, Lee E S, Jahng Y, Kim D H, Jeong T C. Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry.  Rapid Commun Mass Spectrom. 2004;  18 1073-80
• 15 Wrighton S A, Stevens J C. The human hepatic cytochromes P450 involved in drug metabolism.  Crit Rev Toxicol. 1992;  22 1-21